Cargando…
Parking CAR T Cells in Tumours: Oncolytic Viruses as Valets or Vandals?
SIMPLE SUMMARY: Chimeric Antigen Receptor (CAR) modified T cell therapy has revolutionized the treatment of B cell malignancies, however transposition of the technology to the solid tumour setting has been met with more therapeutic resistance. Oncolytic Viruses (OVs) are multi-modal agents, possessi...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7961585/ https://www.ncbi.nlm.nih.gov/pubmed/33807553 http://dx.doi.org/10.3390/cancers13051106 |